Tech Center 1600 • Art Units: 1626
This examiner grants 76% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17093833 | OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS | Non-Final OA | Merck Sharp & Dohme LLC |
| 17618829 | AMINO ACID TRANSPORT INHIBITORS AND THE USES THEREOF | Final Rejection | VANDERBILT UNIVERSITY |
| 18330171 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | Non-Final OA | AbbVie Inc. |
| 18030105 | SMALL MOLECULE NICOTINAMIDE ADENINE DINUCLEOTIDE MODULATORS | Non-Final OA | THE CLEVELAND CLINIC FOUNDATION |
| 18295582 | TETRAPYRROLE-BASED COMPOUNDS AND THEIR FOMULATIONS FOR ANTI-MICROBIAL THERAPY | Non-Final OA | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 18007296 | SELECTIVE PHOSPHATASE INHIBITORS BASED ON ILLUDALIC ACID | Non-Final OA | WEST VIRGINIA UNIVERSITY BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIVERSITY |
| 18453798 | COMPOUNDS AND METHODS FOR MODULATING HER2 | Non-Final OA | Iambic Therapeutics, Inc. |
| 18262326 | ANTI-VIRAL AGENT | Non-Final OA | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY |
| 18267277 | NITROGENOUS HETEROAROMATIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Non-Final OA | UDC IRELAND LIMITED |
| 18557217 | PROCESS FOR PREPARING PEXIDARTINIB | Non-Final OA | JOHNSON MATTHEY PUBLIC LIMITED COMPANY |
| 17350374 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS | Final Rejection | SYNGENTA PARTICIPATIONS AG |
| 18263227 | CYCLOPROPYLAMIDE COMPOUNDS AGAINST PARASITES IN FISH | Non-Final OA | Corteva Agriscience LLC |
| 18571386 | DAPRODUSTAT FOR REDUCING FATIGUE IN A SUBJECT WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE | Non-Final OA | GlaxoSmithKline Intellectual Property (No.2) Limited |
| 18462120 | HETEROATOM SUBSTITUTED CYCLIC AND ALKYL AMINES AS ACTIVATORS OF SEROTONIN RECEPTORS | Non-Final OA | ATAI Therapeutics, Inc. |
| 18211840 | NANOMATERIALS COMPRISING CARBONATES | Non-Final OA | Beam Therapeutics Inc. |
| 18365343 | BIPHENYL COMPOUNDS CONTAINING SUBSTITUTED SULFIDE (SULFOXIDE) GROUPS AND USES THEREOF | Non-Final OA | SHENYANG UNIVERSITY OF CHEMICAL TECHNOLOGY |
| 18030757 | Deuterated Camptothecin Derivative And Antibody-drug Conjugate Thereof | Non-Final OA | Baili-Bio (Chengdu) Pharmaceutical Co., Ltd. |
| 18043609 | ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION | Final Rejection | Christian-Albrechts-Universitat Zu Kiel |
| 18020916 | SPIRO COMPOUND AND APPLICATION THEREOF | Non-Final OA | SICHUAN AG-RAY NEW MATERIALS CO., LTD |
| 18004064 | SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | Non-Final OA | NURAY CHEMICALS PRIVATE LIMITED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy